The ballots are counted, the run-off elections are complete, and a new administration and Congress are set to begin. You may recall that the mock election that was held during the 2008 Annual Scientific Meeting—78% of U.S. meeting attendees chose Barack Obama as their next president—and the general election echoed that choice. On January 20, Barack Obama was sworn in as the United States’ 44th President.
Search results for: Biologics
Measuring Quality of Care Is Here to Stay—and the ACR Can Help
Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
Biologic Logic: Making Sense of Current Therapies for Rheumatic Diseases
Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.
Drug Updates
Information on safety, labeling changes, and pharmaceutical research
Meet the HEP C Challenge
Keep a hepatitis C virus infection from hindering RA treatment
Experts Debate Merits of Peripheral MRI in Diagnosing RA
New technology comes with a host of pros and cons
A Regulatory Leader in Rheumatology
Jeffrey Siegel, MD: A rare combination of clinical scientist and regulatory collaborator
The Race Between Senators McCain and Obama
At one time, Senators John McCain and Barack Obama were both considered the underdog choices to receive nominations for the 2008 presidential election.
Study Groups: Where Information and Networking Mix
ACR study groups provide an excellent forum for networking at the ACR/ARHP Annual Scientific Meeting and are among the most highly sought-after sessions each year. Although study groups are not eligible for CME credits, they provide an opportunity for the exchange of new ideas and in-depth presentations of information. These groups give attendees the opportunity to discuss cases and share experiences with colleagues who share a common interest in one disease, a group of related disorders, or a specialized field of study.
Drug Safety
What can the ACR do?